This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun 27;5(1):66.
doi: 10.1186/s40249-016-0160-7.

Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results

Affiliations

Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results

Afework H Tekle et al. Infect Dis Poverty. .

Abstract

Background: The African Programme for Onchocerciasis Control (APOC) was created in 1995 to establish community-directed treatment with ivermectin (CDTi) in order to control onchocerciasis as a public health problem in 20 African countries that had 80 % of the global disease burden. When research showed that CDTi may ultimately eliminate onchocerciasis infection, APOC was given in 2008 the additional objective to determine when and where treatment can be safely stopped. We report the results of epidemiological evaluations undertaken from 2008 to 2014 to assess progress towards elimination in CDTi areas with ≥6 years treatment.

Methods: Skin snip surveys were undertaken in samples of first-line villages to determine the prevalence of O. volvulus microfilariae. There were two evaluation phases. The decline in prevalence was evaluated in phase 1A. Observed and model-predicted prevalences were compared after correcting for endemicity level and treatment coverage. Bayesian statistics and Monte Carlo simulation were used to classify the decline in prevalence as faster than predicted, on track or delayed. Where the prevalence approached elimination levels, phase 1B was launched to determine if treatment could be safely stopped. Village sampling was extended to the whole CDTi area. Survey data were analysed within a Bayesian framework to determine if stopping criteria (overall prevalence <1.4 % and maximum stratum prevalence <5 %) were met.

Results: In phase 1A 127 665 people from 639 villages in 54 areas were examined. The prevalence had fallen dramatically. The decline in prevalence was faster than predicted in 23 areas, on track in another 23 and delayed in eight areas. In phase 1B 108 636 people in 392 villages were examined in 22 areas of which 13 met the epidemiological criteria for stopping treatment. Overall, 32 areas (25.4 million people) had reached or were close to elimination, 18 areas (17.4 million) were on track but required more years treatment, and in eight areas (10.4 million) progress was unsatisfactory.

Conclusions: Onchocerciasis has been largely controlled as a public health problem. Great progress has been made towards elimination which already appears to have been achieved for millions of people. For most APOC countries, nationwide onchocerciasis elimination is within reach.

Keywords: APOC; Community-directed treatment; Elimination; Ivermectin; ONCHOSIM; Onchocerciasis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Conceptual framework for onchocerciasis elimination
Fig. 2
Fig. 2
Predicted trends in the prevalence of mf by pre-control endemicity level
Fig. 3
Fig. 3
Observed mf prevalences in surveyed villages against predicted trends for three pre-control endemicity ranges: a. high (CMFL > 30mf/s), b. moderate (10 mf/s < CMFL ≤ 30 mf/s) and c. low (CMFL ≤ 10 mf/s)
Fig. 4
Fig. 4
Observed mf prevalences for evaluation areas with evidence that treatment coverage was lower than reported
Fig. 5
Fig. 5
Map of the APOC countries showing the location and classification of the 58 evaluation areas

References

    1. World Health Organization . Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control. Geneva: World Health Organization; 1995. pp. 1–104. - PubMed
    1. Kim YE, Remme JH, Steinmann P, Stolk WA, Roungou JB, Tediosi F. Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa. PLoS Negl Trop Dis. 2015;9(4):e0003664. doi: 10.1371/journal.pntd.0003664. - DOI - PMC - PubMed
    1. Zoure HG, Noma M, Tekle AH, Amazigo UV, Diggle PJ, Giorgi E, Remme JH. The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected. Parasit Vectors. 2014;7:326. doi: 10.1186/1756-3305-7-326. - DOI - PMC - PubMed
    1. O'Hanlon SJ, Slater HC, Cheke RA, Boatin BA, Coffeng LE, Pion SD, Boussinesq M, Zoure HG, Stolk WA, Basanez MG. Model-Based Geostatistical Mapping of the Prevalence of Onchocerca volvulus in West Africa. PLoS Negl Trop Dis. 2016;10(1):e0004328. - PMC - PubMed
    1. Amazigo U. The African Programme for Onchocerciasis Control (APOC) Ann Trop Med Parasitol. 2008;102(Suppl 1):19–22. doi: 10.1179/136485908X337436. - DOI - PubMed

LinkOut - more resources

Full text links
BioMed Central full text link BioMed Central Free PMC article
Cite

AltStyle によって変換されたページ (->オリジナル) /